Royal Decree implementing Article 37, paragraph 16a, paragraph 1, paragraph 3°, and paragraph 4 of the Law on compulsory medical care insurance and benefits, coordinated on 14 July 1994, as regards oxygen therapy oxyconcentrators during the COVID-19 crisis FILIP, King of Belgium, to all who are now and will be listed below, Our Greet. Having regard to the law on compulsory medical care insurance and benefits, coordinated on 14 July 1994, Article 37, paragraph 16a, paragraph 1, paragraph 3°, inserted by the Programme Act (I) of 27 December 2006, and paragraph 4th, inserted by the Programme Act (I) of 27 December 2006, having regard to the opinion of the Medical Insurance Committee, given on 12 October 2020, having regard to the opinion of the Finance inspector, given on 22 November 2020; Having regard to the agreement of the State Secretary of Budget of 26 November 2020; Having regard to the opinion 68.595/2 of the Council of State, given on 19 January 2021, pursuant to Article 84, paragraph 1, paragraph 2 of the Laws, to the Laws of the Laws of January 1973, adopted on 22 November 2020;the product 2° The name of the applicant (as included in the list) 3° The CE certificate 4° The instructions for use. Art. 3. There shall be no additional charges charged to the patient. Art. 4. On a monthly basis the Institute may publish an updated list on the website http://www.riziv.fgov.be, with the registration and/or removal of an oxyconcentrator. Art. 5. All pricing operations and all payments of insurance institutions shall be carried out by means of tariff services approved by the Minister, in accordance with the provisions of Article 165 of the Law on compulsory medical care and benefits, coordinated on 14 July 1994. Art. 6. This decision shall enter into force on the day of publication in the Belgian Official Journal and shall enter into force on 31 December 2021. Art. 7. The Minister for Social Affairs is responsible for the implementation of this decision.263-521 5,51 0,00 A VIVISOL concentrateteur d'oxygène Yuwell/ VIVISOL oxygen concentratetor Yuwell (Vivisol B) 4263-505 31,80 4263-513 90,10 4263-497 5,51 0,00 0,00 Honorarium of the pharmacist for the supervision of therapy and the coordination of tarification / Honoraires du pharmacien pour l'accompaggenement de la thérapie et la coordination de la tarification Cat. Code Name and packaging Dénomination et condition Compensation basis Base de remboursement I II A 4004-941 Honorarium of the pharmacist for the supervision of the therapy and coordination of the tarification / Honoraires du pharmacien pour l'accompaggenement de la thérapie et la coordination de la tarification P6,70 0,00 0,00 Seeing to be added to our decision of 26 January 2021 for the implementation of the first paragraph of Article 37, 16a, 3° and fourth paragraph of the law concerning the compulsory insurance of 14 July 1994 for the treatment of oxygen for the treatment and for the prevention of diseases.